Toward Therapeutic Intervention of Cancer by Vitamin D Compounds

This publication has 32 references indexed in Scilit:

• Prevention of Preneoplastic Mammary Lesion Development by a Novel Vitamin D Analogue, 1 -Hydroxyvitamin D5
  JNCI Journal of the National Cancer Institute, 1997
• The nuclear receptor superfamily: The second decade
  Cell, 1995
• Growth Attenuation in a Human Prostate Cell Line Mediated by a Phorbol Ester
  Experimental Biology and Medicine, 1995
• Growth Regulation and Cellular Changes during Differentiation of Human Prostatic Cancer LNCaP Cells as Induced by T Lymphocyte-Conditioned Medium
  Experimental Cell Research, 1995
• Vitamin D3 analogs: Effect on leukemic clonal growth and differentiation, and on serum calcium levels
  Leukemia Research, 1995
• Induction of apoptosis in breast cancer cells in response to vitamin D and antiestrogens
  Biochemistry and Cell Biology, 1994
• Differentiation of Cultured Human Melanoma Cells Induced by the Aromatic Fatty Acids Phenylacetate and Phenylbutyrate
  Journal of Investigative Dermatology, 1994
• Effects of a new synthetic vitamin D analogue, EB1089, on the oestrogen-responsive growth of human breast cancer cells
  Journal of Endocrinology, 1994
• Induction of glioma cell death by 1,25 (OH)₂ vitamin D₃: Towards an endocrine therapy of brain tumors?
  Journal of Neuroscience Research, 1994
• Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate.
  Journal of Clinical Investigation, 1993